Mast Therapeutics Inc (MSTX.A)

MSTX.A on American Stock Exchange

0.44USD
10:50am EDT
Price Change (% chg)

$-0.00 (-0.90%)
Prev Close
$0.44
Open
$0.45
Day's High
$0.46
Day's Low
$0.43
Volume
62,057
Avg. Vol
80,935
52-wk High
$0.87
52-wk Low
$0.41

MSTX.A

Chart for MSTX.A

About

Mast Therapeutics, Inc., formerly ADVENTRX Pharmaceuticals, Inc., is a development-stage company biopharmaceutical company focused on developing product candidates. The Company's product candidate is ANX-188, a rheologic, antithrombotic and cytoprotective agent that improves microvascular blood flow and has application in... (more)

Overall

Beta: 1.34
Market Cap (Mil.): $44.18
Shares Outstanding (Mil.): 96.27
Dividend: --
Yield (%): --

Financials

  MSTX.A Industry Sector
P/E (TTM): -- 47.13 37.76
EPS (TTM): -0.36 -- --
ROI: -35.87 -2.58 18.76
ROE: -37.96 -2.66 19.59
Search Stocks

Competitors

  Price Change
Pfizer Inc. (PFE.N) $29.06 -0.17
Johnson & Johnson (JNJ.N) $93.90 +0.40
Roche Holding Ltd. (ROG.VX) CHF228.00 -3.50
Sanofi SA (SASY.PA) €76.85 -3.32
GlaxoSmithKline plc (GSK.L) 1,712.50p +28.50

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ Quantitative Report
$69.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks